RS2 Healthcare Partners Takes Stake in Medtech Manufacturer KMM Group
Boston – September 24, 2026 -- RS2 Healthcare Partners has completed an investment in KMM Group, a Hatboro, Pennsylvania-based precision contract manufacturer for the medical device industry, marking the Boston private equity firm's first new platform deal since narrowing its focus exclusively to lower middle-market healthcare investing.
RS2 names industry veteran J. Mark King as KMM's new CEO
J. Mark King, who brings more than 30 years of medical device industry experience, has been appointed President and Chief Executive Officer of KMM. King previously served as President and CEO of Tegra Medical, a medical device contract manufacturer and former RS2 portfolio company, and has also acted as an advisor to KMM prior to the deal.
"I am honored and excited to continue building on KMM's momentum," King said, citing a long working history with RS2's principals.